Opens in a new tab

Clinical Trial Interest

We have paused trial enrollment for Cybin EMBRACE for the rest of 2026 and may resume in 2027. We will be enrolling for Compass Pathways Redefine Study (COMP202) for the rest of 2027. Check back here for more information or contact us at [email protected]. 

<script
    id="c1e52deb-4c3b-4719-a359-570a4e21f92d-script"
    src="https://app.hipaatizer.com/shared/hipaatizer-form-renderer.js?workflowId=c1e52deb-4c3b-4719-a359-570a4e21f92d"
></script>

<script>
    new Hipaatizer(
        "c1e52deb-4c3b-4719-a359-570a4e21f92d",
        false,
        "",
        false,
    ).render();
</script>